Is GANESHBE undervalued compared to its fair value, analyst forecasts and its price relative to the market?
Valuation Score
2/6
Valuation Score 2/6
Below Fair Value
Significantly Below Fair Value
Price-To-Earnings vs Peers
Price-To-Earnings vs Industry
Price-To-Earnings vs Fair Ratio
Analyst Forecast
Share Price vs Fair Value
What is the Fair Price of GANESHBE when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.
Below Fair Value: Insufficient data to calculate GANESHBE's fair value for valuation analysis.
Significantly Below Fair Value: Insufficient data to calculate GANESHBE's fair value for valuation analysis.
Key Valuation Metric
Which metric is best to use when looking at relative valuation for GANESHBE?
Key metric: As GANESHBE is profitable we use its Price-To-Earnings Ratio for relative valuation analysis.
The above table shows the Price to Earnings ratio for GANESHBE. This is calculated by dividing GANESHBE's market cap by their current
earnings.
What is GANESHBE's PE Ratio?
PE Ratio
15.4x
Earnings
₹632.60m
Market Cap
₹9.74b
GANESHBE key valuation metrics and ratios. From Price to Earnings, Price to Sales and Price to Book to Price to Earnings Growth Ratio, Enterprise Value and EBITDA.
Key Statistics
Enterprise Value/Revenue
2.2x
Enterprise Value/EBITDA
10x
PEG Ratio
n/a
Price to Earnings Ratio vs Peers
How does GANESHBE's PE Ratio compare to its peers?
Price-To-Earnings vs Industry: GANESHBE is good value based on its Price-To-Earnings Ratio (15.4x) compared to the Indian Chemicals industry average (32.4x).
Price to Earnings Ratio vs Fair Ratio
What is GANESHBE's PE Ratio
compared to its
Fair PE Ratio?
This is the expected PE Ratio taking into
account the company's forecast earnings growth, profit margins
and other risk factors.
GANESHBE PE Ratio vs Fair Ratio.
Fair Ratio
Current PE Ratio
15.4x
Fair PE Ratio
n/a
Price-To-Earnings vs Fair Ratio: Insufficient data to calculate GANESHBE's Price-To-Earnings Fair Ratio for valuation analysis.
Analyst Price Targets
What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?
Analyst Forecast: Insufficient data to show price forecast.